跳至主要内容
临床试验/EUCTR2006-001389-18-AT
EUCTR2006-001389-18-AT进行中(未招募)1 期

Comparison of Combined Therapy of Intravitreal Injection of Bevacizumab and Pegaptanib versus Mono-therapy (The MAAM Study) - MAAM-Study

udwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery0 个研究点目标入组 60 人开始时间: 2006年8月31日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • age > 50 years
  • predominantly occult CNV
  • greatest diameter of the lesion < 5400µm
  • distance acuity > 0.1
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Any of the following will exclude a subject from the study:
  • Complicating general disorders inflicting with healing process
  • vision threatening diseases other than CNV
  • Prior treatment for CNV
  • Ophthalmic surgery within 4 weeks

研究者

发起方
udwig Boltzmann Institute forRetinology and Biomicroscopic Laser Surgery

相似试验

Comparison of Combined Therapy of Intravitreal... | 临床试验